atenolol has been researched along with Pregnancy in 96 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atenolol use may be associated with growth retardation when given in pregnancy, although the relationship to trimester of initiation, duration of treatment, and its use as monotherapy is still uncertain." | 9.09 | Atenolol and fetal growth in pregnancies complicated by hypertension. ( Beevers, DG; Beevers, M; Lip, GY; Lydakis, C, 1999) |
| "This study assessed the effectiveness of atenolol in the treatment of moderate and severe hypertension during pregnancy." | 9.07 | Effectiveness of atenolol in the treatment of hypertension during pregnancy. ( Alvarez, L; Baglivo, HP; Cerrato, C; Drisaldi, S; Esper, RJ; Fabregues, G; Moschettoni, C; Pituelo, D; Varas Juri, P, 1992) |
| "29 women with pregnancy induced hypertension in the third trimester, 13 randomised to atenolol and 16 to pindolol." | 9.07 | Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. ( Ingemarsson, I; Marsál, K; Montan, S; Sjöberg, NO, 1992) |
| "Atenolol given from the end of the first trimester in patients with mild hypertension is associated with intrauterine growth retardation." | 9.06 | Atenolol in essential hypertension during pregnancy. ( Butters, L; Kennedy, S; Rubin, PC, 1990) |
| "Atenolol was compared with placebo in a randomised and double-blind prospective study of 120 women with mild to moderate pregnancy-associated hypertension who were also initially managed conventionally by bed rest." | 9.05 | Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. ( Butters, L; Clark, DM; Low, RA; Reid, JL; Reynolds, B; Rubin, PC; Steedman, D; Sumner, DJ, 1983) |
| "The obstetric implications of the use of the beta-adrenoceptor antagonist atenolol have been evaluated in a prospective, randomized, double-blind, and placebo-controlled study involving 120 women with pregnancy-associated hypertension." | 9.05 | Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. ( Belfield, A; Butters, L; Clark, D; Low, RA; Pledger, D; Reid, JL; Rubin, PC; Sumner, D, 1984) |
| "We describe the results of a prospective study in which 120 women who developed hypertension in the last trimester of pregnancy were randomly allocated in double blind manner to atenolol or placebo." | 9.05 | First year of life after the use of atenolol in pregnancy associated hypertension. ( Adams, T; Butters, L; Evans, J; Reynolds, B; Rubin, PC, 1984) |
| "The salivary activity in pups of spontaneously hypertensive rats (SHR) and Wistar (W) rats treated with atenolol during pregnancy, and lactation was evaluated." | 7.74 | Atenolol reduces salivary activity in pups of spontaneously hypertensive and normotensive rats treated during pregnancy and lactation. ( Antoniali, C; Delbem, AC; Elias, GP; Sassaki, KT, 2008) |
| "A retrospective review of patients treated in early pregnancy with atenolol was conducted." | 7.71 | Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. ( Brateng, D; Carr, DB; Diederichs, C; Easterling, TR; Schmucker, B, 2001) |
| "To investigate the possible harmful effects of early antihypertensive drug therapy with atenolol versus other therapies on pregnancy outcome, we reviewed the records of 398 women referred to our antenatal hypertension clinic between 1980 and 1995." | 7.69 | Effect of atenolol on birth weight. ( Beevers, DG; Beevers, M; Churchill, D; Lip, GY; Shaffer, LM, 1997) |
| "Adenosine is effective in rapidly terminating maternal narrow complex tachyarrhythmias before and during delivery in women with Wolff-Parkinson-White syndrome." | 7.68 | Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome. ( Afridi, I; Moise, KJ; Rokey, R, 1992) |
| "Slow-release nifedipine has been used in the treatment of severe hypertension in 23 pregnant women." | 7.67 | Nifedipine as a second line antihypertensive drug in pregnancy. ( Beevers, DG; Constantine, G; Luesley, DM; Reynolds, AL, 1987) |
| "Fetal circulation was studied by means of combined real-time and pulsed Doppler ultrasound in 14 women with pregnancy-associated hypertension before and during the first and third days of treatment with the beta 1-selective blocker, atenolol; in seven of the women the maternal uterine arcuate blood velocity waveform was also studied." | 7.67 | Fetal and uteroplacental haemodynamics during short-term atenolol treatment of hypertension in pregnancy. ( Liedholm, H; Lingman, G; Marsál, K; Montan, S; Sjöberg, NO; Solum, T, 1987) |
| "1 The pharmacological properties of atenolol suggest its possible usefulness in pregnancy-induced hypertension." | 7.66 | Atenolol in the treatment of pregnancy-induced hypertension. ( Cruickshank, JM; McAinsh, J; Thorley, KJ, 1981) |
| "Atenolol has been studied prospectively in the management of ten patients with essential hypertension during pregnancy." | 7.66 | Atenolol in the treatment of essential hypertension during pregnancy. ( Butters, L; Low, RA; Reid, JL; Rubin, PC, 1982) |
| "This study reports the results that were obtained in 56 cases of arterial hypertension in pregnancy solely by beta-blocking with Atenolol or Labetalol." | 7.66 | [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol]. ( Beauséjour, B; Blazquez, G; Faurie, C; Flouvat, B; Gérard, J; Lardoux, H; Rousset, D, 1983) |
| "Treatment with atenolol reduced the incidence of preeclampsia from 5 of 28 (18%) to 1 of 28 (3." | 6.69 | Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. ( Brateng, D; Brown, Z; Easterling, TR; Millard, SP; Schmucker, B, 1999) |
| "Early treatment of high cardiac output with atenolol decreases the risk for preeclampsia." | 5.35 | Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy. ( Brateng, DA; Carr, DB; Easterling, TR; Karumanchi, SA; Kawamura, C; Shofer, JB; Tran, LT, 2009) |
| " The average daily dosage was 144." | 5.27 | Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol. ( Blazquez, G; Chouty, F; Flouvat, B; Gerard, J; Lardoux, H, 1983) |
| "To study clinical efficiency of atenolol in pregnancy hypertension with consideration of its cardiodynamic effects." | 5.09 | [Atenolol use in gestosis: clinical and hemodynamic aspects]. ( Elokhina, TB; Petrova, SB; Shekhtman, MM; Sokolova, MIu, 2000) |
| "Atenolol use may be associated with growth retardation when given in pregnancy, although the relationship to trimester of initiation, duration of treatment, and its use as monotherapy is still uncertain." | 5.09 | Atenolol and fetal growth in pregnancies complicated by hypertension. ( Beevers, DG; Beevers, M; Lip, GY; Lydakis, C, 1999) |
| "To evaluate the short-term effects of intravenously given atenolol and pindolol on utero- and umbilicoplacental vascular impedance, fetal hemodynamics and cardiac function in patients suffering from pregnancy-induced hypertension." | 5.08 | Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study. ( Jouppila, P; Räsänen, J, 1995) |
| "This study assessed the effectiveness of atenolol in the treatment of moderate and severe hypertension during pregnancy." | 5.07 | Effectiveness of atenolol in the treatment of hypertension during pregnancy. ( Alvarez, L; Baglivo, HP; Cerrato, C; Drisaldi, S; Esper, RJ; Fabregues, G; Moschettoni, C; Pituelo, D; Varas Juri, P, 1992) |
| "29 women with pregnancy induced hypertension in the third trimester, 13 randomised to atenolol and 16 to pindolol." | 5.07 | Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. ( Ingemarsson, I; Marsál, K; Montan, S; Sjöberg, NO, 1992) |
| "Atenolol given from the end of the first trimester in patients with mild hypertension is associated with intrauterine growth retardation." | 5.06 | Atenolol in essential hypertension during pregnancy. ( Butters, L; Kennedy, S; Rubin, PC, 1990) |
| "Atenolol was compared with placebo in a randomised and double-blind prospective study of 120 women with mild to moderate pregnancy-associated hypertension who were also initially managed conventionally by bed rest." | 5.05 | Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. ( Butters, L; Clark, DM; Low, RA; Reid, JL; Reynolds, B; Rubin, PC; Steedman, D; Sumner, DJ, 1983) |
| "The obstetric implications of the use of the beta-adrenoceptor antagonist atenolol have been evaluated in a prospective, randomized, double-blind, and placebo-controlled study involving 120 women with pregnancy-associated hypertension." | 5.05 | Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. ( Belfield, A; Butters, L; Clark, D; Low, RA; Pledger, D; Reid, JL; Rubin, PC; Sumner, D, 1984) |
| "We describe the results of a prospective study in which 120 women who developed hypertension in the last trimester of pregnancy were randomly allocated in double blind manner to atenolol or placebo." | 5.05 | First year of life after the use of atenolol in pregnancy associated hypertension. ( Adams, T; Butters, L; Evans, J; Reynolds, B; Rubin, PC, 1984) |
| " The incidence of severe hypertension was significantly lower when nifedipine (odds ratio, 0." | 5.05 | Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. ( Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V, 2020) |
| "Our findings suggest that neonates born to mothers exposed to β blockers in late pregnancy, including labetalol, are at elevated risk for neonatal hypoglycemia and bradycardia." | 3.83 | Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. ( Bateman, BT; Desai, RJ; Fischer, MA; Hernandez-Diaz, S; Huybrechts, KF; Maeda, A; Mogun, H; Patorno, E; Seely, EW, 2016) |
| "The salivary activity in pups of spontaneously hypertensive rats (SHR) and Wistar (W) rats treated with atenolol during pregnancy, and lactation was evaluated." | 3.74 | Atenolol reduces salivary activity in pups of spontaneously hypertensive and normotensive rats treated during pregnancy and lactation. ( Antoniali, C; Delbem, AC; Elias, GP; Sassaki, KT, 2008) |
| "While furosemide improved the hyperdynamic circulation in pregnancy, it did not lower blood pressure or cause clinically significant vasoconstriction." | 3.74 | Maternal hemodynamic changes associated with furosemide treatment. ( Brateng, D; Carr, DB; Easterling, TR; Gavrila, D, 2007) |
| "Changes in FHR and autonomic tones were studied (i) after electrical vagal stimulation and (ii) during nitroprusside-induced hypotension, in seven late gestation ovine fetus in control condition (ctrl), after dobutamine (beta1-activation) and atenolol (beta1-blockade)." | 3.73 | Influence of sympathetic tone on heart rate during vagal stimulation and nitroprusside induced hypotension in ovine fetus. ( Beuchée, A; Carré, F; Gaillot, T; Jaillard, S; Nuyt, AM; Pladys, P; Storme, L, 2005) |
| "A retrospective review of patients treated in early pregnancy with atenolol was conducted." | 3.71 | Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. ( Brateng, D; Carr, DB; Diederichs, C; Easterling, TR; Schmucker, B, 2001) |
| "Atenolol taken at the time of conception and/or during the first trimester of pregnancy was associated with low birth weight." | 3.71 | Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester? ( Bayliss, H; Beevers, DG; Beevers, M; Churchill, D, 2002) |
| "To investigate the possible harmful effects of early antihypertensive drug therapy with atenolol versus other therapies on pregnancy outcome, we reviewed the records of 398 women referred to our antenatal hypertension clinic between 1980 and 1995." | 3.69 | Effect of atenolol on birth weight. ( Beevers, DG; Beevers, M; Churchill, D; Lip, GY; Shaffer, LM, 1997) |
| "Adenosine is effective in rapidly terminating maternal narrow complex tachyarrhythmias before and during delivery in women with Wolff-Parkinson-White syndrome." | 3.68 | Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome. ( Afridi, I; Moise, KJ; Rokey, R, 1992) |
| "Increased motor activity and poor performance in the active avoidance test were observed in the offspring of rats treated with dl-propranolol or sotalol during pregnancy, but not with atenolol and d-propranolol." | 3.68 | Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists. ( Gitter, S; Gordon, I; Rehavi, M; Speiser, Z, 1991) |
| "To assess the problem of continuing atenolol in a breast-feeding mother with hypertension associated with thyrotoxicosis, studies were performed to determine simultaneous plasma and breast milk concentrations of atenolol after a single dose of 50 mg and on continuous therapy of varying weekly dosages." | 3.67 | Atenolol in human plasma and breast milk. ( Andreoli, JW; Cohn, RD; White, WB; Wong, SH, 1984) |
| "Forty term patients with pregnancy-induced hypertension were treated with the beta 1-adrenoceptor blocker atenolol (Tenormin R; ICI) for at least 7 days prior to parturition." | 3.67 | Influence of the beta 1-adrenoceptor blocker atenolol on antenatal cardiotocography. ( Montan, S; Sjöberg, NO; Solum, T, 1984) |
| "The transfer of atenolol and metoprolol to human breast milk was studied in 7 lactating women with hypertension." | 3.67 | Atenolol and metoprolol. A comparison of their excretion into human breast milk. ( Kulas, J; Lunell, NO; Rane, A; Rosing, U; Stéen, B, 1984) |
| "Slow-release nifedipine has been used in the treatment of severe hypertension in 23 pregnant women." | 3.67 | Nifedipine as a second line antihypertensive drug in pregnancy. ( Beevers, DG; Constantine, G; Luesley, DM; Reynolds, AL, 1987) |
| "Fetal circulation was studied by means of combined real-time and pulsed Doppler ultrasound in 14 women with pregnancy-associated hypertension before and during the first and third days of treatment with the beta 1-selective blocker, atenolol; in seven of the women the maternal uterine arcuate blood velocity waveform was also studied." | 3.67 | Fetal and uteroplacental haemodynamics during short-term atenolol treatment of hypertension in pregnancy. ( Liedholm, H; Lingman, G; Marsál, K; Montan, S; Sjöberg, NO; Solum, T, 1987) |
| "Atenolol has been studied prospectively in the management of ten patients with essential hypertension during pregnancy." | 3.66 | Atenolol in the treatment of essential hypertension during pregnancy. ( Butters, L; Low, RA; Reid, JL; Rubin, PC, 1982) |
| "This study reports the results that were obtained in 56 cases of arterial hypertension in pregnancy solely by beta-blocking with Atenolol or Labetalol." | 3.66 | [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol]. ( Beauséjour, B; Blazquez, G; Faurie, C; Flouvat, B; Gérard, J; Lardoux, H; Rousset, D, 1983) |
| "Maternal and umbilical serum concentrations of atenolol, a hydrophilic, cardioselective beta-adrenoceptor antagonist, were studied at delivery in seven cases of pregnancy hypertension." | 3.66 | Transplacental passage of atenolol in man. ( Ingemarsson, I; Liedholm, H; Melander, A; Niklasson, B; Scherstén, B; Sjöberg, NO, 1978) |
| "1 The pharmacological properties of atenolol suggest its possible usefulness in pregnancy-induced hypertension." | 3.66 | Atenolol in the treatment of pregnancy-induced hypertension. ( Cruickshank, JM; McAinsh, J; Thorley, KJ, 1981) |
| "Atenolol therapy was not randomized." | 2.70 | The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. ( Brateng, D; Carr, DB; Desai, M; Easterling, TR; McDonald, GB; Thach, CT, 2001) |
| "Treatment with atenolol reduced the incidence of preeclampsia from 5 of 28 (18%) to 1 of 28 (3." | 2.69 | Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. ( Brateng, D; Brown, Z; Easterling, TR; Millard, SP; Schmucker, B, 1999) |
| "Myocardial infarction is rare in pregnancy." | 2.39 | Myocardial infarction in a parturient. A case report with emphasis on medication and management. ( Haring, P; Hietakorpi, S; Koski, E; Nuutinen, LS; Purhonen, S; Söderlin, MK, 1994) |
| " Data were collected during 1 dosing interval from lactating women treated with atenolol for therapeutic reasons, at 2 to 4 weeks (n = 32), 3 to 4 months (n = 22), and 6 to 8 months (n = 17) postpartum." | 1.36 | Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum. ( Anderson, GD; Brateng, DA; Buchanan, ML; Carr, D; Easterling, TR; Eyal, S; Hebert, MF; Kim, JD; Woodrum, DE, 2010) |
| "Hyperdynamic patients had less preeclampsia, less severe preeclampsia, fewer deliveries <34 weeks, and fewer neonatal intensive care unit days compared with those requiring a vasodilator." | 1.35 | Outcomes of pregnancies at risk for hypertensive complications managed using impedance cardiography. ( Chaffin, DG; Webb, DG, 2009) |
| "Early treatment of high cardiac output with atenolol decreases the risk for preeclampsia." | 1.35 | Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy. ( Brateng, DA; Carr, DB; Easterling, TR; Karumanchi, SA; Kawamura, C; Shofer, JB; Tran, LT, 2009) |
| "Levobupivacaine was substituted for routine racemic bupivacaine to decrease the risk of drug-induced cardiotoxicity." | 1.33 | Long QT syndrome: anaesthetic management at delivery. ( Behl, S; Wauchob, TD, 2005) |
| "Her pregnancy was complicated by uncontrolled hypertension, which was not associated with other markers of disease activity." | 1.32 | Successful pregnancy in a patient with Takayasus arteritis. ( Al-Ghamdi, AA, 2003) |
| "Pregnancy is associated with altered vascular reactivity." | 1.31 | Pregnancy alters adrenergic mechanisms in uterine arterioles of rats. ( Datta, S; Segal, S; Wang, SY, 2002) |
| " The average daily dosage was 144." | 1.27 | Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol. ( Blazquez, G; Chouty, F; Flouvat, B; Gerard, J; Lardoux, H, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 42 (43.75) | 18.7374 |
| 1990's | 21 (21.88) | 18.2507 |
| 2000's | 22 (22.92) | 29.6817 |
| 2010's | 9 (9.38) | 24.3611 |
| 2020's | 2 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Bellos, I | 1 |
| Pergialiotis, V | 1 |
| Papapanagiotou, A | 1 |
| Loutradis, D | 1 |
| Daskalakis, G | 1 |
| Elias, GP | 2 |
| Araujo, HC | 1 |
| Sassaki, KT | 2 |
| Delbem, ACB | 1 |
| Antoniali, C | 2 |
| Duan, L | 2 |
| Ng, A | 2 |
| Chen, W | 2 |
| Spencer, HT | 2 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 2 |
| Thomas, SK | 1 |
| Sheffield, JS | 1 |
| Roberts, SW | 1 |
| Tsirkin, VI | 1 |
| Nozdrachev, AD | 1 |
| Korotaeva, YV | 1 |
| Gómez Torrijos, E | 1 |
| García Rodríguez, C | 1 |
| Sánchez Caminero, MP | 1 |
| Castro Jiménez, A | 1 |
| García Rodríguez, R | 1 |
| Feo-Brito, F | 1 |
| Lengellé, C | 1 |
| Bejan-Angoulvant, T | 1 |
| Beau-Salinas, F | 1 |
| Jonville-Béra, AP | 1 |
| Bateman, BT | 1 |
| Patorno, E | 1 |
| Desai, RJ | 1 |
| Seely, EW | 1 |
| Mogun, H | 1 |
| Maeda, A | 1 |
| Fischer, MA | 1 |
| Hernandez-Diaz, S | 1 |
| Huybrechts, KF | 1 |
| Carr, DB | 5 |
| Tran, LT | 1 |
| Brateng, DA | 3 |
| Kawamura, C | 1 |
| Shofer, JB | 1 |
| Karumanchi, SA | 1 |
| Easterling, TR | 8 |
| Chaffin, DG | 1 |
| Webb, DG | 1 |
| Keating, E | 1 |
| Gonçalves, P | 1 |
| Campos, I | 1 |
| Costa, F | 1 |
| Martel, F | 1 |
| Eyal, S | 1 |
| Kim, JD | 1 |
| Anderson, GD | 2 |
| Buchanan, ML | 1 |
| Carr, D | 1 |
| Woodrum, DE | 1 |
| Hebert, MF | 2 |
| Goya, M | 1 |
| Alvarez, M | 1 |
| Teixido-Tura, G | 1 |
| Merced, C | 1 |
| Pineda, V | 1 |
| Evangelista, A | 1 |
| Bayliss, H | 2 |
| Churchill, D | 3 |
| Beevers, M | 3 |
| Beevers, DG | 4 |
| Damron, DP | 1 |
| Shinkai, N | 1 |
| Takasuna, K | 1 |
| Takayama, S | 1 |
| Al-Ghamdi, AA | 1 |
| Darcie, S | 1 |
| Leone, CR | 1 |
| Calil, VM | 1 |
| Prescinotti, EP | 1 |
| Kahhale, S | 1 |
| Zugaib, M | 1 |
| Arxer, A | 1 |
| Pardina, B | 1 |
| Blas, I | 1 |
| Ramió, L | 1 |
| Villalonga, A | 1 |
| Blough, D | 1 |
| Green, GE | 1 |
| Kantor, E | 1 |
| Benedetti, TJ | 2 |
| Behl, S | 1 |
| Wauchob, TD | 1 |
| Gaillot, T | 1 |
| Beuchée, A | 1 |
| Jaillard, S | 1 |
| Storme, L | 1 |
| Nuyt, AM | 1 |
| Carré, F | 1 |
| Pladys, P | 1 |
| Zwiers, WJ | 1 |
| Blodgett, TM | 1 |
| Vallejo, MC | 1 |
| Finegold, H | 1 |
| Gavrila, D | 1 |
| Brateng, D | 4 |
| Delbem, AC | 1 |
| Fuerst, M | 1 |
| Dubois, D | 1 |
| Petitcolas, J | 1 |
| Temperville, B | 1 |
| Klepper, A | 1 |
| Catherine, P | 1 |
| Rubin, PC | 7 |
| Butters, L | 5 |
| Clark, DM | 1 |
| Reynolds, B | 2 |
| Sumner, DJ | 1 |
| Steedman, D | 1 |
| Low, RA | 3 |
| Reid, JL | 3 |
| Smith, AM | 1 |
| Walker, H | 1 |
| Bonduelle, M | 1 |
| Greer, I | 1 |
| Calder, AA | 1 |
| Lardoux, H | 3 |
| Gerard, J | 3 |
| Blazquez, G | 3 |
| Flouvat, B | 3 |
| Crankshaw, DJ | 1 |
| Ruzycky, AL | 1 |
| Ingemarsson, I | 3 |
| Liedholm, H | 4 |
| Montan, S | 5 |
| Westgren, M | 1 |
| Melander, A | 3 |
| Clark, D | 1 |
| Sumner, D | 1 |
| Belfield, A | 1 |
| Pledger, D | 1 |
| Evans, J | 1 |
| Adams, T | 1 |
| Kulas, J | 1 |
| Lunell, NO | 2 |
| Rosing, U | 1 |
| Stéen, B | 1 |
| Rane, A | 1 |
| Solum, T | 2 |
| Sjöberg, NO | 5 |
| Galletly, DC | 1 |
| Yee, P | 1 |
| Maling, TJ | 1 |
| Chouty, F | 1 |
| Beauséjour, B | 1 |
| Faurie, C | 1 |
| Rousset, D | 1 |
| White, WB | 2 |
| Andreoli, JA | 1 |
| Andreoli, JW | 1 |
| Wong, SH | 1 |
| Cohn, RD | 1 |
| Fowler, MB | 1 |
| Brudenell, M | 1 |
| Jackson, G | 1 |
| Holt, DW | 1 |
| Woods, DL | 1 |
| Morrell, DF | 1 |
| Thorley, KJ | 2 |
| Steyer, M | 1 |
| Poleska, W | 1 |
| Diemer, HP | 1 |
| Schmidt, H | 1 |
| Heidenreich, J | 1 |
| Bitzén, PO | 1 |
| Helm, G | 1 |
| Lönnerholm, G | 1 |
| Mattiasson, I | 1 |
| Nilsson, B | 1 |
| Wåhlin-Boll, E | 1 |
| McAinsh, J | 1 |
| Cruickshank, JM | 1 |
| Söderlin, MK | 1 |
| Purhonen, S | 1 |
| Haring, P | 1 |
| Hietakorpi, S | 1 |
| Koski, E | 1 |
| Nuutinen, LS | 1 |
| Shalev, Y | 1 |
| Ben-Hur, H | 1 |
| Hagay, Z | 1 |
| Blickstein, I | 1 |
| Epstein, M | 1 |
| Ayzenberg, O | 1 |
| Gelven, A | 1 |
| Caspi, A | 1 |
| Pearce, SH | 1 |
| Rees, CJ | 1 |
| Smith, RH | 1 |
| Shi, CZ | 1 |
| Zhuang, LZ | 1 |
| Räsänen, J | 1 |
| Jouppila, P | 1 |
| Crichton, F | 1 |
| Ohashi, T | 1 |
| Hashimoto, S | 1 |
| Morikawa, K | 1 |
| Kato, H | 1 |
| Ito, Y | 1 |
| Asano, M | 1 |
| Azuma, H | 1 |
| Lawrenson, JB | 1 |
| Okreglicki, AM | 1 |
| Millar, RN | 1 |
| Lip, GY | 2 |
| Shaffer, LM | 1 |
| Lydakis, C | 1 |
| Ellis, MR | 1 |
| Kane, KY | 1 |
| Beevers, G | 1 |
| Carbonne, B | 1 |
| Jannet, D | 1 |
| Milliez, J | 1 |
| Schmucker, B | 2 |
| Brown, Z | 1 |
| Millard, SP | 1 |
| Shekhtman, MM | 1 |
| Elokhina, TB | 1 |
| Petrova, SB | 1 |
| Sokolova, MIu | 1 |
| Diederichs, C | 1 |
| McDonald, GB | 1 |
| Desai, M | 1 |
| Thach, CT | 1 |
| Rollins, G | 1 |
| Wang, SY | 1 |
| Datta, S | 1 |
| Segal, S | 1 |
| Persson, B | 1 |
| Aragon, G | 1 |
| Fredholm, BB | 1 |
| Aström, H | 1 |
| Niklasson, B | 1 |
| Scherstén, B | 1 |
| Hodgson, BJ | 1 |
| Fremming, BD | 1 |
| Daly, S | 1 |
| Afridi, I | 1 |
| Moise, KJ | 1 |
| Rokey, R | 1 |
| Marsál, K | 2 |
| Shen, JJ | 1 |
| Wanwimolruk, S | 1 |
| Mills, RG | 1 |
| Roberts, MS | 1 |
| Speiser, Z | 1 |
| Gordon, I | 1 |
| Rehavi, M | 1 |
| Gitter, S | 1 |
| Fabregues, G | 1 |
| Alvarez, L | 1 |
| Varas Juri, P | 1 |
| Drisaldi, S | 1 |
| Cerrato, C | 1 |
| Moschettoni, C | 1 |
| Pituelo, D | 1 |
| Baglivo, HP | 1 |
| Esper, RJ | 1 |
| Blake, S | 1 |
| MacDonald, D | 1 |
| Mader, SL | 1 |
| Mackall, JA | 1 |
| Emert, MP | 1 |
| Kennedy, S | 1 |
| Cruickshank, DJ | 1 |
| Campbell, DM | 1 |
| Diamond, JM | 1 |
| Kawecka-Jaszcz, K | 1 |
| Skoczeń, M | 1 |
| Schneider, H | 1 |
| Proegler, M | 1 |
| Lyons, CW | 1 |
| Colmorgen, GH | 1 |
| Viinikka, L | 1 |
| Ylikorkala, O | 1 |
| Schmucker, BC | 1 |
| Carlson, KL | 1 |
| Schimmel, MS | 1 |
| Eidelman, AI | 1 |
| Wilschanski, MA | 1 |
| Shaw, D | 1 |
| Ogilvie, RJ | 1 |
| Koren, G | 1 |
| Schmimmel, MS | 1 |
| Eidelman, AJ | 1 |
| Hanretty, KP | 1 |
| Whittle, MJ | 1 |
| Tucker, DC | 1 |
| Gist, R | 1 |
| Constantine, G | 1 |
| Reynolds, AL | 1 |
| Luesley, DM | 1 |
| Olofsson, P | 1 |
| Sartor, G | 1 |
| Katz, V | 1 |
| Blanchard, G | 1 |
| Dingman, C | 1 |
| Bowes, WA | 1 |
| Cefalo, RC | 1 |
| Lingman, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Maternal Hemodynamic Monitoring in Women Undergoing Cesarean Section by Use of NICaS Cardiac Impedance[NCT02902068] | 200 participants (Actual) | Observational | 2016-05-31 | Completed | |||
| Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)[NCT03269110] | 2,578 participants (Anticipated) | Observational | 2017-07-01 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for atenolol and Pregnancy
| Article | Year |
|---|---|
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease | 2020 |
Myocardial infarction in a parturient. A case report with emphasis on medication and management.
Topics: Adult; Aspirin; Atenolol; Delivery, Obstetric; Drug Therapy, Combination; Female; Humans; Myocardial | 1994 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Ox | 1985 |
19 trials available for atenolol and Pregnancy
| Article | Year |
|---|---|
Chronic hypertension in pregnancy.
Topics: Atenolol; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; F | 2002 |
Glycemia in newborns of hypertensive mothers according to maternal treatment.
Topics: Antihypertensive Agents; Apgar Score; Atenolol; Blood Glucose; Epidemiologic Methods; Female; Fetal | 2004 |
Beta-blockers may have role in preeclampsia.
Topics: Adrenergic beta-Antagonists; Atenolol; Birth Weight; Clinical Trials as Topic; Female; Humans; Hyper | 1982 |
Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension.
Topics: Adult; Atenolol; Bed Rest; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Hu | 1983 |
Antihypertensive therapy in pregnancy.
Topics: Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Labetalol; Ma | 1983 |
Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol.
Topics: Atenolol; Clinical Trials as Topic; Delivery, Obstetric; Double-Blind Method; Female; Fetal Heart; F | 1984 |
First year of life after the use of atenolol in pregnancy associated hypertension.
Topics: Atenolol; Body Height; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; H | 1984 |
Atenolol: side effects in the newborn infant.
Topics: Atenolol; Female; Humans; Hypertension; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pregnan | 1982 |
Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Female; Fetal Heart; Hemodyna | 1995 |
Atenolol and fetal growth in pregnancies complicated by hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Embryonic and Fetal Development; Female; Humans; Hypertens | 1999 |
Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Birth Weight; Cardiac Output; Double-Blind Method; Fem | 1999 |
[Atenolol use in gestosis: clinical and hemodynamic aspects].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Female; Gestational Age; Hemodynamics; Humans; Hyperte | 2000 |
The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia.
Topics: Adult; Antigens, CD; Antihypertensive Agents; Atenolol; Cardiac Output, High; Female; Fibronectins; | 2001 |
Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics.
Topics: Atenolol; Blood Pressure; Double-Blind Method; Female; Fetus; Heart Rate; Hemodynamics; Humans; Hype | 1992 |
Effectiveness of atenolol in the treatment of hypertension during pregnancy.
Topics: Adult; Atenolol; Female; Humans; Hypertension; Parity; Pregnancy; Pregnancy Complications, Cardiovas | 1992 |
The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment.
Topics: Adult; Atenolol; Bendroflumethiazide; Birth Weight; Drug Therapy, Combination; Embryonic and Fetal D | 1991 |
Atenolol in essential hypertension during pregnancy.
Topics: Atenolol; Birth Weight; Blood Pressure; Double-Blind Method; Female; Fetal Growth Retardation; Gesta | 1990 |
Atenolol in essential hypertension during pregnancy.
Topics: Atenolol; Female; Fetal Growth Retardation; Humans; Hypertension; Labetalol; Pregnancy; Pregnancy Co | 1990 |
Effects of beta 1-adrenoceptor blockade in the treatment of hypertension during pregnancy in diabetic women.
Topics: Adult; Atenolol; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertensi | 1986 |
74 other studies available for atenolol and Pregnancy
| Article | Year |
|---|---|
Atenolol increases dental mineralization in male offspring of treated hypertensive rats and normotensive rats.
Topics: Animals; Atenolol; Dental Enamel; Dentin; Female; Hardness; Hypertension; Male; Pregnancy; Rats; Rat | 2020 |
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Beta-blocker subtypes and risk of low birth weight in newborns.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Birth Weight; California; Fem | 2018 |
Thionamide-induced neutropenia and ecthyma in a pregnant patient with hyperthyroidism.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Antithyroid Agents; Atenolol; Drug Eruptions; Ecthyma | 2013 |
An endogenous sensitizer of β adrenergic receptors and its analogs attenuate the inhibition of β adrenergic receptors by propranolol and atenolol in the rat myocardium.
Topics: Adrenergic beta-Antagonists; Amino Acids; Animals; Atenolol; Female; Heart; Humans; Myocardial Contr | 2014 |
First case report of acute generalized exanthematous pustulosis due to labetalol.
Topics: Acute Generalized Exanthematous Pustulosis; Adrenergic Antagonists; Adult; Antihypertensive Agents; | 2015 |
[Drugs news].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Anti-Obesity Agents; Anticonvu | 2015 |
Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.
Topics: Adrenergic beta-Antagonists; Atenolol; Bradycardia; Cohort Studies; Female; Humans; Hypertension; Hy | 2016 |
Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiac Output, High; Female; Hemodynamics; Humans; Longit | 2009 |
Outcomes of pregnancies at risk for hypertensive complications managed using impedance cardiography.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiography, Impedance; Female; Hemodynamics; Humans; Inf | 2009 |
Folic acid uptake by the human syncytiotrophoblast: interference by pharmacotherapy, drugs of abuse and pathological conditions.
Topics: Amphetamine; Antihypertensive Agents; Atenolol; Biological Transport; Cell Survival; Cells, Cultured | 2009 |
Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum.
Topics: Adult; Antihypertensive Agents; Atenolol; Dose-Response Relationship, Drug; Female; Follow-Up Studie | 2010 |
Abdominal aortic dilatation during pregnancy in Marfan syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Atenolol; Ce | 2012 |
Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester?
Topics: Antihypertensive Agents; Atenolol; Embryonic and Fetal Development; Female; Humans; Hypertension; In | 2002 |
Tocolytic activity of formoterol against premature delivery in mice.
Topics: Adrenergic Agonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; | 2002 |
Successful pregnancy in a patient with Takayasus arteritis.
Topics: Adult; Antihypertensive Agents; Atenolol; Cesarean Section; Female; Humans; Pregnancy; Pregnancy Com | 2003 |
Dural sinus thrombosis in a late preeclamptic woman.
Topics: Adult; Anticoagulants; Antihypertensive Agents; Atenolol; Cerebral Veins; Female; Heparin; Humans; M | 2004 |
Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum.
Topics: Adult; Atenolol; Creatinine; Female; Humans; Hypertension, Pregnancy-Induced; Milk, Human; Postpartu | 2005 |
Long QT syndrome: anaesthetic management at delivery.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Analgesics, Opioid; Anesthetics, Local; Anti-Arr | 2005 |
Influence of sympathetic tone on heart rate during vagal stimulation and nitroprusside induced hypotension in ovine fetus.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Atenolol; B | 2005 |
Successful vaginal delivery for a parturient with complete aortic coarctation.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anesthetics, Intravenous; Anesthetics, Local; Ao | 2006 |
Maternal hemodynamic changes associated with furosemide treatment.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiac Output; Diuretics; Female; Follow- | 2007 |
Atenolol reduces salivary activity in pups of spontaneously hypertensive and normotensive rats treated during pregnancy and lactation.
Topics: Adrenergic beta-Antagonists; Amylases; Animals; Atenolol; Female; Hypertension; Lactation; Male; Org | 2008 |
Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Topics: Abnormalities, Drug-Induced; Acebutolol; Adrenergic beta-Antagonists; Adult; Apgar Score; Atenolol; | 1982 |
Beta-blockers for pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Labetalol; Pregnancy; Pregnancy | 1983 |
Which beta-blocker in pregnancy-induced hypertension?
Topics: Atenolol; Birth Weight; Ethanolamines; Female; Humans; Hypertension; Infant, Newborn; Labetalol; Pre | 1983 |
Characterization of putative beta-adrenoceptors in the myometrium of the pregnant ewe: correlation between the binding of [3H] dihydroalprenolol and the inhibition of myometrial contractility in vitro.
Topics: Adrenergic beta-Agonists; Albuterol; Alprenolol; Animals; Atenolol; Dihydroalprenolol; Dose-Response | 1984 |
Fetal heart rate during treatment of maternal hypertension with beta-adrenergic antagonists. A preliminary report.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Fetal Heart; Heart Rate; Humans; Hypertension; Pindol | 1984 |
Beta blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Kinetics; Methyldopa; Oxprenolo | 1984 |
Atenolol and metoprolol. A comparison of their excretion into human breast milk.
Topics: Atenolol; Female; Fetal Blood; Humans; Hypertension; Metoprolol; Milk, Human; Pregnancy; Pregnancy C | 1984 |
Influence of the beta 1-adrenoceptor blocker atenolol on antenatal cardiotocography.
Topics: Apgar Score; Atenolol; Birth Weight; Female; Fetal Heart; Fetal Monitoring; Heart Rate; Humans; Hype | 1984 |
Anaesthetic management of combined caesarean section and phaeochromocytoma removal.
Topics: Adrenal Gland Neoplasms; Adult; Anesthesia, General; Atenolol; Cesarean Section; Female; Humans; Lab | 1983 |
Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.
Topics: Adolescent; Adult; Atenolol; Ethanolamines; Female; Fetus; Humans; Hypertension; Infant, Newborn; La | 1983 |
[Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
Topics: Adolescent; Adult; Atenolol; Delivery, Obstetric; Ethanolamines; Female; Fetal Heart; Fetal Monitori | 1983 |
Painless postpartum thyroiditis seen initially as severe hypertension.
Topics: Adult; Atenolol; Diagnosis, Differential; Female; Humans; Hypertension; Pregnancy; Puerperal Disorde | 1984 |
Atenolol in human plasma and breast milk.
Topics: Adult; Atenolol; Female; Humans; Hypertension; Infant, Newborn; Milk, Human; Pregnancy; Puerperal Di | 1984 |
Essential hypertension and pregnancy: successful outcome with atenolol.
Topics: Adult; Atenolol; Female; Fetal Blood; Humans; Hypertension; Maternal-Fetal Exchange; Pregnancy; Preg | 1984 |
Atenolol: side effects in a newborn infant.
Topics: Atenolol; Bradycardia; Female; Humans; Hypertension; Hypotension; Infant, Newborn; Male; Maternal-Fe | 1982 |
Atenolol: side effects in a newborn infant.
Topics: Atenolol; Female; Humans; Hypertension; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal E | 1982 |
Atenolol in the treatment of essential hypertension during pregnancy.
Topics: Atenolol; Blood Pressure; Female; Fetus; Heart Rate; Humans; Hypertension; Infant, Newborn; Pregnanc | 1982 |
Combined use of beta-sympathomimetic drugs and beta-blockers during labour.
Topics: Atenolol; Blood Pressure; Ethanolamines; Female; Fenoterol; Heart Rate; Humans; Metoprolol; Obstetri | 1981 |
Accumulation of atenolol and metoprolol in human breast milk.
Topics: Atenolol; Female; Humans; Kinetics; Lactation; Metoprolol; Milk, Human; Pregnancy; Propanolamines | 1981 |
Atenolol in the treatment of pregnancy-induced hypertension.
Topics: Adult; Atenolol; Female; Fetus; Humans; Hypertension; Kinetics; Pregnancy; Pregnancy Complications, | 1981 |
Successful delivery following myocardial ischemia during the second trimester of pregnancy.
Topics: Acute Disease; Adult; Atenolol; Cardiac Catheterization; Coronary Angiography; Female; Heparin; Huma | 1993 |
Fetal monitoring during maternal antiarrhythmic therapy.
Topics: Adenosine; Adult; Atenolol; Cardiotocography; Drug Therapy, Combination; Female; Humans; Infant, New | 1993 |
Stimulatory effect of norepinephrine on progesterone production by human first trimester placenta explants in vitro.
Topics: Atenolol; Clonidine; Culture Media, Serum-Free; Cyclic AMP; Female; Gadolinium; Gonadotropin-Releasi | 1993 |
Beta blockers in pregnancy and their effect on regional Doppler ultrasound and fetal weight.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Body Weight; Female; Fet | 1996 |
Potent inhibition of spontaneous rhythmic contraction by a novel beta 2-adrenoceptor agonist, HSR-81, in pregnant rat uterus.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; | 1996 |
Cardiovascular collapse due to intravenous verapamil in two patients with persistent atrial tachycardia.
Topics: Adult; Atenolol; Cardiac Output, Low; Female; Furosemide; Humans; Infusions, Intravenous; Male; Midd | 1995 |
Effect of atenolol on birth weight.
Topics: Analysis of Variance; Anthropometry; Antihypertensive Agents; Atenolol; Birth Weight; Female; Fetal | 1997 |
Atenolol for prevention of preeclampsia.
Topics: Antihypertensive Agents; Atenolol; Birth Weight; Cardiac Output; Double-Blind Method; Female; Humans | 1999 |
Fetal growth restriction.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Female; Fetal Growth Re | 2000 |
Fetal growth restriction.
Topics: Antihypertensive Agents; Atenolol; Bias; Blood Pressure; Clinical Trials as Topic; Female; Fetal Gro | 2000 |
Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiac Output; Embryonic and Fetal Development; Female; G | 2001 |
Guidelines on high blood pressure in pregnancy give new classifications of disease.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Contra | 2000 |
Pregnancy alters adrenergic mechanisms in uterine arterioles of rats.
Topics: Animals; Arterioles; Atenolol; Colforsin; Female; Isoproterenol; Phenylephrine; Pregnancy; Pregnancy | 2002 |
Circulatory and metabolic effects of acute beta 1-blockade in severe pre-eclampsia.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; Blood Pressure; Cyclic AMP; | 1979 |
Transplacental passage of atenolol in man.
Topics: Adult; Atenolol; Female; Half-Life; Humans; Infant, Newborn; Maternal-Fetal Exchange; Placenta; Preg | 1978 |
Effects of adrenergic drugs administered during ovum transport and chemical sympathectomy of the oviduct on fertility in rabbits.
Topics: Animals; Ascorbic Acid; Atenolol; Autonomic Agents; Embryo Implantation; Fallopian Tubes; Female; Fe | 1975 |
Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome.
Topics: Adenosine; Adult; Atenolol; Electrocardiography; Female; Heart Rate, Fetal; Humans; Obstetric Labor | 1992 |
Response to beta-blockers in maternal and fetal rat hearts in vitro.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Female; Heart; Heart Rate; Isoproterenol; Labetalol; | 1991 |
Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atenolol; Avoidance Le | 1991 |
Hyperadrenergic orthostatic intolerance as a result of postpartum blood loss.
Topics: Adult; Atenolol; Chronic Disease; Female; Fludrocortisone; Fluid Therapy; Humans; Hypotension, Ortho | 1990 |
Toxic effects of atenolol consumed during breast feeding.
Topics: Atenolol; Breast Feeding; Female; Humans; Infant; Maternal-Fetal Exchange; Milk, Human; Pregnancy | 1989 |
Placental transfer of beta-adrenergic antagonists studied in an in vitro perfusion system of human placental tissue.
Topics: Adrenergic beta-Antagonists; Atenolol; Celiprolol; Female; Humans; In Vitro Techniques; Labetalol; M | 1988 |
Medical management of pheochromocytoma in pregnancy.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Atenolol; Cesarean Section; Female; Hu | 1988 |
Beta blockers inhibit fetal thromboxane A2 production in vitro.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Platelets; Female; Fetal Blood; Humans; Infant, Newborn | 1988 |
Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring.
Topics: Atenolol; Cardiac Output; Female; Hemodynamics; Humans; Hydralazine; Hypertension; Pregnancy; Pregna | 1989 |
Toxic effects of atenolol consumed during breast feeding.
Topics: Atenolol; Breast Feeding; Female; Humans; Hypertension; Infant, Newborn; Milk, Human; Pregnancy; Pue | 1989 |
Reappearance of end-diastolic velocity in a pregnancy complicated by severe pregnancy-induced hypertension.
Topics: Adult; Atenolol; Blood Flow Velocity; Diastole; Female; Humans; Hypertension; Pre-Eclampsia; Pregnan | 1988 |
Sympathetic innervation alters growth and intrinsic heart rate of fetal rat atria maturing in oculo.
Topics: Animals; Anterior Chamber; Atenolol; Atropine Derivatives; Catecholamines; Denervation; Female; Feta | 1986 |
Nifedipine as a second line antihypertensive drug in pregnancy.
Topics: Adult; Atenolol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypertensio | 1987 |
Atenolol and short umbilical cords.
Topics: Animals; Atenolol; Female; Fetal Movement; Pregnancy; Rabbits; Risk; Umbilical Cord | 1987 |
Fetal and uteroplacental haemodynamics during short-term atenolol treatment of hypertension in pregnancy.
Topics: Adult; Atenolol; Blood Flow Velocity; Blood Pressure; Female; Fetal Blood; Heart Rate; Heart Rate, F | 1987 |